Trade names Acofide (JP) ATC code None Metabolism | Routes ofadministration By mouth (tablets) Protein binding 84.21–85.95% Molar mass 450.55 g/mol | |
 | ||
Legal status US: Not approvedRx-only (JP) Route Oral administration (Tablet) | ||
How to pronounce acotiamide
Acotiamide (brand name Acofide, codenamed YM-443 and Z-338) is a drug approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. It acts as an acetylcholinesterase inhibitor.
References
Acotiamide Wikipedia(Text) CC BY-SA